These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10050145)

  • 1. [Attitude change of Spanish cardiologist with respect to hypolipidemic treatment in secondary prevention. The role of outside hospital care].
    Plaza Pérez I; Taboada Taboada M; Bautista Herrero Jimeno J; Gómez Guindal JA; Román León MT
    Rev Esp Cardiol; 1998; 51 Suppl 6():54-62. PubMed ID: 10050145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of hyperlipemia: opinions of primary care physicians of the La Rioja region].
    Brea Hernando AJ; Villar Arias MA; Mosquera Lozano JD; Ramírez Alesón MV
    Med Clin (Barc); 1996 Mar; 106(11):409-13. PubMed ID: 8637293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk assessment and treatment to target low density lipoprotein levels in hospitalized ischemic heart disease patients: results of the HOLEM study.
    Harats D; Leibovitz E; Maislos M; Wolfovitz E; Chajek-Shaul T; Leitersdorf E; Gavish D; Gerber Y; Goldbourt U;
    Isr Med Assoc J; 2005 Jun; 7(6):355-9. PubMed ID: 15984375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Why the cardiologists should be interested in lipids?].
    López-Sendón JL; Rubio R; López de Sá E; Delcán JL
    Rev Esp Cardiol; 1995; 48 Suppl 2():23-32. PubMed ID: 7569272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.
    Vale MJ; Jelinek MV; Best JD; Dart AM; Grigg LE; Hare DL; Ho BP; Newman RW; McNeil JJ;
    Arch Intern Med; 2003 Dec 8-22; 163(22):2775-83. PubMed ID: 14662633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention secondary to ischemic cardiopathy at the lipid level in primary care in Aragon. PRECIAR study 1].
    Martínez Hernández AA; Aguilar Leñero MJ; Rabadán Mengíbar M; Hernansanz Iglesias F; González Ramos J; Marín Obáñez A
    Rev Esp Salud Publica; 2001; 75(2):143-9. PubMed ID: 11400424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of lipid lowering in patients with coronary artery disease by case method learning.
    Kiessling A; Zethraeus N; Henriksson P
    Int J Technol Assess Health Care; 2005; 21(2):180-6. PubMed ID: 15921057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protecting the heart: a practical review of the statin studies.
    Ong HT
    MedGenMed; 2002 Dec; 4(4):1. PubMed ID: 12817199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary prevention and cardiac rehabilitation in Spain. Section of Preventive Cardiology].
    Plaza Pérez I; Velasco Rami JA; Maroto Montero JM
    Rev Esp Cardiol; 1996 Aug; 49(8):549-53. PubMed ID: 8756199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How concerned are elderly patients without coronary heart disease about hypercholesterolemia and heart disease? An UPRNet study. Upper Peninsula Research Network.
    Reddy E; Kreher N; Hickner JM
    J Fam Pract; 1998 Mar; 46(3):227-32. PubMed ID: 9519020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients.
    Rajmohan L; Deepa R; Mohan A; Mohan V
    Indian Heart J; 2000; 52(4):400-6. PubMed ID: 11084779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of compliance with lipid guidelines in an academic medical center.
    Schwiesow SJ; Nappi JM; Ragucci KR
    Ann Pharmacother; 2006 Jan; 40(1):27-31. PubMed ID: 16352778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypolipemic treatment in prevention of secondary ischemic heart disease].
    Nessler J
    Przegl Lek; 1998; 55(5):259-65. PubMed ID: 9741193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors.
    Krobot KJ; Yin DD; Alemao E; Steinhagen-Thiessen E
    Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):37-45. PubMed ID: 15703504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE; Feely J; Sigurdsson EL;
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study.
    Leibovitz E; Harats D; Gavish D
    Isr Med Assoc J; 2002 Jun; 4(6):407-10. PubMed ID: 12073409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.